MOSCOW — Russia’s Sputnik V vaccine against COVID-19 could be produced in Europe for the first time after a commercial deal to produce it in Italy was signed by the Moscow-based RDIF sovereign wealth fund and Swiss-based pharmaceutical company Adienne.
The agreement, which will need approval from Italian regulators before production can be launched, has been confirmed by both RDIF and the Italian-Russian chamber of commerce.
It is the latest evidence that some European Union members are not willing to wait for the EU’s own regulator — the European Medicines Agency (EMA) — to grant its approval to Sputnik V.
Scientists said the Russian vaccine was almost 92% effective, ba…
Keep on reading: Sputnik V could be made in Europe for first time after Italy deal signed